CompletedNCT02675075

DESIPHER_Speech Degradation as an Indicator of Physiological Degeneration in ALS

Studying Amyotrophic lateral sclerosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
VA Office of Research and Development
Principal Investigator
Samuel L. Phillips, PhD
James A. Haley Veterans' Hospital, Tampa, FL
Enrollment
34 enrolled
Eligibility
18 years · All sexes
Timeline
20162017

Study locations (1)

Collaborators

Florida Institute for Human and Machine Cognition

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02675075 on ClinicalTrials.gov

Other trials for Amyotrophic lateral sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Amyotrophic lateral sclerosis

← Back to all trials